DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVAX (Q2019359)

From EU Knowledge Graph
Revision as of 04:48, 2 November 2020 by DG Regio (talk | contribs) (‎Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement)
Jump to navigation Jump to search
Project Q2019359 in Italy
Language Label Description Also known as
English
DEVELOPMENT OF A PLATFORM FOR IDENTIFICATION OF MUTANOA AND PERSONALISED VACCINATION IN CANCER PATIENTS — PRCIVAX
Project Q2019359 in Italy

    Statements

    0 references
    565,360.84 Euro
    0 references
    761,887.32 Euro
    0 references
    74.21 percent
    0 references
    1 November 2016
    0 references
    31 December 2018
    0 references
    GENOMIX4LIFE SRL
    0 references
    Q277381 (Deleted Item)
    0 references

    40°44'48.98"N, 14°46'11.96"E
    0 references
    BIOTECNOLOGIE (Italian)
    0 references
    BIOTECHNOLOGY (English)
    0 references

    Identifiers

    B18I17000200008
    0 references